The United States spends more on healthcare than any other country, and it’s not particularly close. Health spending now accounts for 17.6% of GDP, and projections from the Centers for Medicare and Medicaid Services put that figure at 20.3% by 2033. That means roughly one in five dollars in the entire economy will flow through the healthcare system. No single villain explains this. Instead, several forces compound on each other, each adding a layer of cost that patients, employers, and taxpayers absorb.
Drug Prices Dwarf the Rest of the World
Prescription drugs are one of the starkest cost gaps between the US and peer nations. A 2022 analysis published through RAND Health Quarterly found that US prices for brand-name drugs were 422% of prices in comparison countries. Even after accounting for the rebates that drug manufacturers pay back to insurers and pharmacy benefit managers, US brand-name prices were still 308% higher than those abroad.
The core reason is that most other wealthy nations negotiate drug prices at a national level, setting caps on what manufacturers can charge. The US has historically left pricing to the market, allowing drugmakers to set prices based on what insurers will pay. While recent legislation has introduced limited Medicare drug price negotiation, the vast majority of the market remains unregulated on price. This doesn’t just affect people buying medications at the pharmacy. High drug costs ripple into hospital bills, insurance premiums, and employer healthcare plans.
Physicians Earn Far More Than Peers Abroad
American doctors are the highest-paid in the world, and the gap is substantial. The average US physician earns around $316,000 per year. In Germany, that figure is $183,000. In the United Kingdom, it’s $138,000. French physicians average $98,000. These salary differences reflect genuine structural factors: US medical education saddles graduates with enormous debt, malpractice insurance premiums are high, and the training pipeline is long and expensive. But the result is that labor costs for clinical care are significantly higher than in comparable systems, and those costs get passed to patients through higher prices for office visits, surgeries, and hospital stays.
Chronic Disease Drives 90% of Spending
The sheer burden of chronic illness in the US is a massive cost engine. According to the CDC, 90% of the nation’s $4.9 trillion in annual health expenditures go toward people with chronic and mental health conditions. Heart disease, diabetes, obesity, chronic lung disease, and cancer require ongoing management: regular doctor visits, daily medications, lab work, imaging, and periodic hospitalizations.
The US has particularly high rates of obesity and type 2 diabetes compared to other wealthy countries, which feeds a cycle of expensive downstream care. A person managing diabetes may need insulin (priced far higher here than elsewhere), quarterly bloodwork, eye exams, kidney monitoring, and eventually treatment for complications like nerve damage or cardiovascular disease. Multiply that across tens of millions of people, and chronic conditions become the single largest category of healthcare spending by a wide margin.
Hospitals Consolidate and Prices Rise
When hospitals merge or acquire physician practices, competition shrinks and prices tend to climb. A Yale study examining hospital takeovers of OB-GYN practices found that within two years, hospital prices for labor and delivery rose by an average of $475 (3.3%), while physicians’ prices for the same services jumped $502 (15.1%). Notably, even doctors who were already part of a hospital system saw their prices increase by 9% after their hospital acquired additional physicians in the same specialty, suggesting that reduced local competition is what drives the price hikes rather than any change in quality or service.
This pattern plays out across specialties and regions. As independent practices get absorbed into larger health systems, those systems gain leverage to negotiate higher reimbursement rates from insurers. Patients in areas with fewer competing hospitals or provider groups have little ability to shop around, and insurers have limited power to push back if a dominant system threatens to leave their network.
The Fee-for-Service Incentive Problem
Most healthcare in the US is still paid for on a fee-for-service basis, meaning providers are reimbursed for each test, procedure, and visit they perform. The more they do, the more they earn. This creates a structural incentive to order more imaging, run more labs, and schedule more follow-ups, even when the clinical benefit is marginal.
The US already performs more high-tech diagnostic exams than nearly any other nation. OECD data from 2021 shows that the combined rate of CT, MRI, and PET scans in the US exceeded 360 exams per 1,000 people, placing it among the highest utilizers globally alongside Luxembourg, South Korea, France, and Austria. Some of this reflects genuine medical need and patient expectations for thorough workups. But a significant portion stems from the financial structure of the system itself.
Fear of malpractice lawsuits amplifies this tendency. So-called defensive medicine, where doctors order tests primarily to protect themselves from litigation rather than because they expect to find something clinically useful, is estimated to cost $46 billion annually. Alternative payment models that reimburse based on patient outcomes rather than volume of services have shown promise. A systematic review of these value-based models found positive improvements in quality outcomes alongside reduced spending and utilization. But the transition away from fee-for-service has been slow.
Administrative Overhead Adds Up
The US healthcare system involves a uniquely complex web of private insurers, employer plans, government programs, and out-of-pocket payments. Each payer has its own coverage rules, billing codes, prior authorization requirements, and appeals processes. Hospitals and physician practices employ large billing and coding departments just to navigate this landscape, and insurers employ equally large teams to process, verify, and sometimes deny claims.
Countries with simpler payer structures, whether single-payer or tightly regulated multi-payer systems, spend a fraction of what the US does on administration. Health administrative expenditures across industrialized nations range from roughly 1% to 7% of total health spending, according to CMS data. The US sits at the high end of that range. This isn’t money that treats a single patient. It’s the cost of running a billing system so fragmented that doctors, hospitals, and insurers each need dedicated staff just to communicate with one another about payment.
Higher Spending Doesn’t Mean Longer Waits Elsewhere
A common assumption is that the US pays more but gets faster access in return. There’s some truth to this for specialist care: in a 2023 comparison of 10 countries, 57% of US patients who needed a specialist saw one within a month, compared to just 31% in Canada. Fewer than one in 50 US patients waited a year or more, while one in 10 Canadians did. But countries like Switzerland (64%), the Netherlands (62%), and Germany (54%) matched or beat the US on specialist wait times while spending considerably less per person. The idea that high spending is the price of fast access doesn’t hold up when you look at the full range of wealthy nations.
Why Costs Keep Growing
Healthcare spending in the US is projected to grow at an average of 5.8% per year through 2033, outpacing GDP growth of 4.3%. That widening gap means healthcare will consume an ever-larger share of the economy, squeezing household budgets, employer compensation, and government programs simultaneously.
The forces described above don’t operate in isolation. They reinforce each other. High drug prices and high provider costs flow into insurance premiums. Fee-for-service incentives generate more utilization. Hospital consolidation reduces the competitive pressure that might otherwise restrain prices. A large and growing population with chronic disease ensures sustained demand for expensive ongoing care. And the administrative machinery required to manage it all adds cost at every step without improving a single health outcome. Each piece is individually fixable in theory, but the combination creates a system where spending momentum is extremely difficult to reverse.